The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Dopamine and L‐dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease
Abstract
Protein deposition diseases involve the aggregation of normally soluble proteins, leading to both fibrillar and amorphous deposits. The aggregation of α‐synuclein is associated with Parkinson's disease, and the aggregation of the Aβ peptide is associated with Alzheimer's disease. Here we show that L‐dopa, dopamine, and other catecholamines dissolve fibrils of α‐synuclein and Aβ peptide generated in vitro. The catecholamines also inhibited the fibrillation of these proteins. In addition, intraneuronal α‐synuclein deposits formed in a mouse model were dissolved by incubation of tissue slices with L‐dopa. These catecholamines are susceptible to oxidative breakdown, and we show that oxidation products are more effective than the parent compounds in inhibition. The ability to dissolve fibrils provides a new approach for studying mechanisms and consequences (e.g., the relationship between fibril formation and neurodegeneration) of protein aggregation. It is also likely to help in the development of strategies for the prevention and treatment of protein deposition diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein damage and degradation by oxygen radicals. I. general aspects.
Davies, K. J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48018-0 · Cited by 1,634
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T
Naiki, H., Higuchi, K., Hosokawa, M., & Takeda, T. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90046-8 · Cited by 1,223
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126
Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096
Self-citationAlzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 875
Carrell, R. W., & Lomas, D. A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02073-4 · Cited by 807
Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
Self-citationAsanuma, M., Miyazaki, I., & Ogawa, N. (2003) · Neurotoxicity Research · doi:10.1007/bf03033137 · Cited by 516
Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein.
Davies, K. J., Lin, S. W., & Pacifici, R. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48021-0 · Cited by 479
Biophysical Properties of the Synucleins and Their Propensities to Fibrillate
Uversky, V. N., Li, J., Souillac, P., Millett, I. S., Doniach, S., Jakes, R., Goedert, M., & Fink, A. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109541200 · Cited by 468
Self-citationHarper, J. D., Wong, S. S., Lieber, C. M., & Lansbury, P. T. (1999) · Biochemistry · doi:10.1021/bi9904149 · Cited by 454
LaVoie, M. J., & Hastings, T. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01484.1999 · Cited by 447
Birkmayer, W., Knoll, J., Riederer, P., Youdim, M. B. H., Hars, V., & Marton, J. (1985) · Journal of Neural Transmission · doi:10.1007/bf01245973 · Cited by 436
β-Synuclein Inhibits α-Synuclein Aggregation
Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M., & Masliah, E. (2001) · Neuron · doi:10.1016/s0896-6273(01)00462-7 · Cited by 398
Ding, T. T., Lee, S.-J., Rochet, J.-C., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020139h · Cited by 356
Jarrett, J. T., & Lansbury, P. T. (1992) · Biochemistry · doi:10.1021/bi00164a008 · Cited by 325
Heiser, V., Scherzinger, E., Boeddrich, A., Nordhoff, E., Lurz, R., Schugardt, N., Lehrach, H., & Wanker, E. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110138997 · Cited by 262
Anti‐amyloidogenic activity of tetracyclines: studies in vitro
Forloni, G., Colombo, L., Girola, L., Tagliavini, F., & Salmona, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02380-2 · Cited by 242
Muralikrishnan, D., & Mohanakumar, K. P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.905 · Cited by 237
Potent Inhibition of Scrapie‐Associated PrP Accumulation by Congo Red
Caughey, B., & Race, R. E. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09437.x · Cited by 233
Rochet, J.-C., Conway, K. A., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi001315u · Cited by 222
Merlini, G., Ascari, E., Amboldi, N., Bellotti, V, Arbustini, E., Perfetti, V, Ferrari, M., Zorzoli, I., Marinone, M. G., & Garini, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2959 · Cited by 205
Inhibition of fibril formation in β-amyloid peptide by a novel series of benzofurans
Howlett, D. R., PERRY, A. E., GODFREY, F., SWATTON, J. E., JENNINGS, K. H., Spitzfaden, C. E., Wadsworth, H., Wood, S. J., & Markwell, R. E. (1999) · Biochemical Journal · doi:10.1042/bj3400283 · Cited by 197
Uversky, V. N., Lee, H.-J., Li, J., Fink, A. L., & Lee, S.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100551200 · Cited by 186
Self-citationInhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.
Howlett, D. R., Perry, A. E., GODFREY, F., et al. (1999) · PubMed · Cited by 180
Assembly of Amyloid Protofibrils via Critical Oligomers—A Novel Pathway of Amyloid Formation
Modler, A. J., Gast, K., Lutsch, G., & Damaschun, G. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01175-0 · Cited by 180
Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization
Findeis, M. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00034-x · Cited by 174
Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers
Yamin, G., Uversky, V. N., & Fink, A. L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00367-3 · Cited by 167
Self-citationNew Class of Inhibitors of Amyloid-β Fibril Formation
Lashuel, H. A., Hartley, D. M., Balakhaneh, D., Aggarwal, A. K., Teichberg, S., & Callaway, D. J. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206593200 · Cited by 163
A Novel Action of Alzheimer's Amyloid β-Protein (Aβ): Oligomeric Aβ Promotes Lipid Release
Michikawa, M., Gong, J., Fan, Q., Sawamura, N., & Yanagisawa, K. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07226.2001 · Cited by 162
Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid β Protein in Vitro
Tomiyama, T., Asano, S., Suwa, Y., Morita, T., Kataoka, K., Mori, H., & Endo, N. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2428 · Cited by 158
Spencer, J. P. E., Jenner, A. M., Butler, J., Aruoma, O. I., Dexter, D. T., Jenner, P. G., & Halliwell, B. B. (1996) · Free Radical Research · doi:10.3109/10715769609088005 · Cited by 144
Parkinsons Disease and other α-Synucleinopathies
Goedert, M. (2001) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2001.047 · Cited by 96
Schmidt, M. L., Robinson, K. A., Lee, V. M., & Trojanowski, J. Q. (1995) · Europe PMC (PubMed Central) · Cited by 73
Rajagopalan, S., & Andersen, J. K. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00283-4 · Cited by 69
Neuroprotection by dopamine agonists
Lange, K. W., Rausch, W., Gsell, W., Naumann, M., Oestreicher, E. M., & Riederer, P. F. (1994) · PubMed · doi:10.5283/epub.25419 · Cited by 63
SEBASTIÃO, M. P., Merlini, G., Saraiva, M. J., & Damas, A. M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510273 · Cited by 43
Cullen, K. M., Halliday, G. M., Cartwright, H., & Kril, J. J. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0025 · Cited by 20
Electrospray tandem mass spectrometry of aminochromes
Amado, F. M. L., Domingues, P. M., Ferrer-Correia, A. J. V., Remião, F., Milhazes, N., Borges, F., Carvalho, F. D., & Bastos, M. D. L. (2001) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.498 · Cited by 17
Forensic neuropathological and immunohistochemical studies on Alzheimer-type dementia (AD/SDAT).
Tatsuno, Y., Yamamoto, Y., Fukunaga, T., et al. (1990) · PubMed · Cited by 2
Cited by
Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation
Uversky, V. N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04764.x · Cited by 567
DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers
Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F., Brooks, D. J., Dickson, D. W., Dubois, B., Emre, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256715.13907.d3 · Cited by 548
deepDR: a network-based deep learning approach to in silico drug repositioning
Zeng, X., Zhu, S., Liu, X., Zhou, Y., Nussinov, R., & Cheng, F. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz418 · Cited by 535
Metadata
- Authors
- Li, J., Zhu, M., Manning-Bog, A. B., Di Monte, D. A., & Fink, A. L.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 18
- Issue
- 9
- Pages
- 962-964
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1968990406
- Cited by
- 258
- References
- 45
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.